SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-055322
Filing Date
2020-11-27
Accepted
2020-11-27 09:01:20
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 odt-s3.htm S-3 219964
2 EX-5.1 odt-ex51_7.htm EX-5.1 20956
3 EX-23.1 odt-ex231_6.htm EX-23.1 2832
4 GRAPHIC garah2rva4aa000002.jpg GRAPHIC 29283
5 GRAPHIC gpbowcsguz5s000001.jpg GRAPHIC 89690
6 GRAPHIC gies1btgsi3q000001.jpg GRAPHIC 11362
7 GRAPHIC garah2rva4aa000001.jpg GRAPHIC 4471
  Complete submission text file 0001564590-20-055322.txt   431100
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-250993 | Film No.: 201352910
SIC: 2834 Pharmaceutical Preparations